These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21896082)

  • 1. Inflammation, immunity, and vaccine development for Helicobacter pylori.
    Müller A; Solnick JV
    Helicobacter; 2011 Sep; 16 Suppl 1():26-32. PubMed ID: 21896082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation, immunity, vaccines for Helicobacter pylori infection.
    Koch M; Meyer TF; Moss SF
    Helicobacter; 2013 Sep; 18 Suppl 1():18-23. PubMed ID: 24011240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori immunology and vaccines.
    Vorobjova T; Watanabe T; Chiba T
    Helicobacter; 2008 Oct; 13 Suppl 1():18-22. PubMed ID: 18783517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity, inflammation, and vaccines for Helicobacter pylori.
    D'Elios MM; Czinn SJ
    Helicobacter; 2014 Sep; 19 Suppl 1():19-26. PubMed ID: 25167941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
    Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
    Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen.
    Inoue K; Shiota S; Yamada K; Gotoh K; Suganuma M; Fujioka T; Ahmed K; Iha H; Nishizono A
    Helicobacter; 2009 Oct; 14(5):135-43. PubMed ID: 19751439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local recall responses in the stomach involving reduced regulation and expanded help mediate vaccine-induced protection against Helicobacter pylori in mice.
    Becher D; Deutscher ME; Simpfendorfer KR; Wijburg OL; Pederson JS; Lew AM; Strugnell RA; Walduck AK
    Eur J Immunol; 2010 Oct; 40(10):2778-90. PubMed ID: 21038469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori inflammation, immunity, and vaccines.
    D'Elios MM; Andersen LP
    Helicobacter; 2007 Oct; 12 Suppl 1():15-9. PubMed ID: 17727455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in vaccine development against Helicobacter pylori.
    Svennerholm AM; Lundgren A
    FEMS Immunol Med Microbiol; 2007 Jul; 50(2):146-56. PubMed ID: 17442014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation, immunity and vaccines for Helicobacter pylori.
    Del Giudice G; Michetti P
    Helicobacter; 2004; 9 Suppl 1():23-8. PubMed ID: 15347302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization.
    Akhiani AA; Stensson A; Schön K; Lycke N
    Scand J Immunol; 2006 Feb; 63(2):97-105. PubMed ID: 16476008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic immunization with an epitope-based vaccine elicits a Th1-biased response and provides protection against Helicobacter pylori in mice.
    Li HB; Zhang JY; He YF; Chen L; Li B; Liu KY; Yang WC; Zhao Z; Zou QM; Wu C
    Vaccine; 2012 Dec; 31(1):120-6. PubMed ID: 23137845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation, immunity, vaccines for Helicobacter infection.
    Chmiela M; Michetti P
    Helicobacter; 2006 Oct; 11 Suppl 1():21-6. PubMed ID: 16925607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation, immunity, and vaccines for Helicobacter pylori.
    D'Elios MM; Andersen LP
    Helicobacter; 2009 Sep; 14 Suppl 1():21-8. PubMed ID: 19712164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current status of Helicobacter pylori vaccines: a review.
    Kabir S
    Helicobacter; 2007 Apr; 12(2):89-102. PubMed ID: 17309745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection.
    Shi T; Liu WZ; Gao F; Shi GY; Xiao SD
    Helicobacter; 2005 Feb; 10(1):71-9. PubMed ID: 15691317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori bacterial ghost containing recombinant Omp18 as a putative vaccine.
    Talebkhan Y; Bababeik M; Esmaeili M; Oghalaei A; Saberi S; Karimi Z; Afkhami N; Mohammadi M
    J Microbiol Methods; 2010 Sep; 82(3):334-7. PubMed ID: 20621134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses.
    Nyström J; Svennerholm AM
    Vaccine; 2007 Mar; 25(14):2591-8. PubMed ID: 17239498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A vaccine against Helicobacter pylori: towards understanding the mechanism of protection.
    Aebischer T; Walduck A; Schroeder J; Wehrens A; Chijioke O; Schreiber S; Meyer TF
    Int J Med Microbiol; 2008 Jan; 298(1-2):161-8. PubMed ID: 17702653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral immunization against Helicobacter pylori--a future concept.
    Michetti P
    J Gastroenterol; 1998; 33 Suppl 10():66-8. PubMed ID: 9840022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.